Vifor Pharma Participations AG

Tweet this page
<
2023
2024
>
Registration as it was on 22 Nov 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

200,000€ - 299,999€

Financial year: Jul 2023 - Jun 2024

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

2

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Vifor Pharma Participations AG

    EU Transparency Register

    283361852096-45 First registered on 28 Nov 2023

    Goals / Remit

    CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need.

    Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

    Main EU files targeted

    Pharmaceutical Package (including OMP legislation), SoHO (substances of human origin) legislation and kidney health

    Address

    Head Office
    Flughofstrasse 61
    Glattbrugg 8152
    SWITZERLAND
    EU Office
    Flughofstrasse 61
    Glattbrugg 8152
    SWITZERLAND

    Website

    https://www.viforpharma.com/

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 05 Feb 2025

    Name Start date End Date
    Annarosa Mezzacasa 19 Nov 2024 18 Nov 2025
    Sandra Anita Ruckstuhl 19 Nov 2024 18 Nov 2025
    Alessandro TEMPRA 15 Dec 2023 04 Oct 2024
    Giulia COLOMBO 25 Jan 2024 04 Oct 2024

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Eucope - The European Confederation of Pharmaceutical Entrepreneurs
    EFPIA - The European Federation of Pharmaceutical Industries and Associations
    EKHA - European Kidney Health Alliance
    Blood & Beyond

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jul 2023 - Jun 2024

    Lobbying costs for closed financial year

    200,000€ - 299,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    acumen public affairs 10,000€ - 24,999€
    dga group europe sa 25,000€ - 49,999€
    incisive health 10,000€ - 24,999€

    Intermediaries for current year

    Name
    dga group europe sa

    Closed year Costs

    200,000€ - 299,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    None declared

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard